Indiva (NDVA) Stock Price, News & Analysis

Company Overview

Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.

Key Stats

• Today's Range: C$0.03 to C$0.04
• 50-Day Range: C$0.03 to C$0.03
• 52-Week Range: C$0.02 to C$0.13
• Volume: 558,384 shs
• Average Volume: 119,038 shs
• Market Capitalization: C$5.86 million
• P/E Ratio: N/A
• Dividend Yield: 4.04%
• Price Target: C$0.15
• Consensus Rating: Buy

NDVA Stock Analysis - Frequently Asked Questions

How have NDVA shares performed this year?

Indiva's stock was trading at C$0.10 at the beginning of 2024. Since then, NDVA stock has decreased by 68.4% and is now trading at C$0.03.
View the best growth stocks for 2024 here.

How do I buy shares of Indiva?

Shares of NDVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Indiva own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Indiva investors own include Meta Platforms (META), Canopy Growth (CGC), 22nd Century Group (XXII), AcelRx Pharmaceuticals (ACRX), Acasti Pharma (ACST), Curaleaf (CURLF) and Fortress Biotech (FBIO).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: CVE:NDVA
• CUSIP: N/A
• CIK: N/A
• Web: indiva.ca
• Phone: 888-649-6686
• Fax: N/A
• Employees: 147,000
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$0.15
• High Stock Price Target: C$0.15
• Low Stock Price Target: C$0.15
• Potential Upside/Downside: +400.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-4,920,000.00
• Net Margins: -13.09%
• Pretax Margin: N/A
• Return on Equity: -544.76%
• Return on Assets: -3.51%

Debt

• Debt-to-Equity Ratio: 5,899.22
• Current Ratio: 0.72
• Quick Ratio: 0.52

Sales & Book Value

• Annual Sales: C$37.57 million
• Price / Sales: 0.16
• Cash Flow: C$0.01 per share
• Price / Cash Flow: 5.20
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 195,490,000
• Free Float: N/A
• Market Cap: C$5.86 million
• Optionable: Not Optionable
• Beta: 1.12